Form 4: Zynex CFO Daniel Moorhead Reports Stock Award and Tax Withholding

Zynex CFO Daniel Moorhead received a restricted stock award and had shares withheld for tax obligations, according to a recent SEC filing.

Summary

• Daniel Moorhead, CFO of Zynex Inc., reported changes in beneficial ownership of the company's stock on September 5, 2024.
• He received a restricted stock award of 5,000 shares of common stock.
• These shares vest equally over four years, starting one year from the grant date.
• The CFO also had 5,250 shares withheld by Zynex to cover income tax obligations related to the settlement of restricted stock awards.
• Following these transactions, Moorhead directly owns 50,634 shares of Zynex common stock and indirectly owns 71,363 restricted stock awards that have not vested.

Sentiment

Score: 6

Explanation: The document reflects standard executive compensation practices. It's neutral in sentiment as it reports routine transactions.

Positives

• The grant of restricted stock aligns the CFO's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the CFO.

Industry Context

Stock awards are a common form of executive compensation in publicly traded companies, aligning management's interests with shareholder value.

Comparison to Industry Standards

• Executive compensation packages, including stock awards, vary significantly across the medical device industry.
• Companies like Medtronic and Stryker also utilize stock awards as part of their executive compensation plans, but the specific terms and amounts depend on company size, performance, and individual roles.
• The vesting schedule of four years is fairly standard for restricted stock awards.

Stakeholder Impact

• The stock award could have a minor positive impact on shareholder sentiment as it aligns management's interests with company performance.
• Employees may view the stock award as a positive sign of the company's commitment to its executives.

Key Dates